OrthoPediatrics Executive and Leadership Team

David Bailey, the President & Chief Executive Officer at OrthoPediatrics, directs the overarching corporate strategy and global market expansion. Overseeing the entire organizational structure, the President & Chief Executive Officer ensures alignment between product development and the specific needs of pediatric patients. This leadership role involves managing relationships with the Board and driving long-term financial growth through the delivery of specialized orthopedic solutions. By prioritizing the design of anatomically appropriate implants, David Bailey maintains the company's competitive edge in the medical device sector. The President & Chief Executive Officer also monitors international operations to ensure consistent quality standards across all regions. Through rigorous oversight of internal processes, the President & Chief Executive Officer secures the company's position as a leader in pediatric trauma and deformity correction, ultimately fostering sustainable value for stakeholders while advancing the standard of care for children worldwide.

Kevin Unger, the President, Enabling Technologies at OrthoPediatrics, architects the integration of advanced surgical systems and digital tools into pediatric orthopedic procedures. Overseeing the development of specialized instruments, the President, Enabling Technologies ensures that surgeons possess the precise equipment required for complex deformity correction. This role involves collaborating with engineering teams to refine product functionality and improve clinical outcomes. By driving innovation in surgical technology, Kevin Unger expands the company's footprint in the sports medicine and trauma markets. The President, Enabling Technologies also manages the implementation of new procedural workflows that enhance operational efficiency within hospitals. Through the strategic deployment of these technologies, the President, Enabling Technologies supports the broader mission of providing anatomically appropriate solutions for children. This focus on technical advancement directly impacts the company's ability to address evolving medical challenges while maintaining high standards of safety and efficacy in pediatric care environments.

Gregory Odle, the President - Scoliosis at OrthoPediatrics, directs the development and commercialization of specialized spinal deformity correction products. Overseeing the scoliosis business unit, the President - Scoliosis ensures that surgeons receive the most effective implants for treating complex spinal conditions in pediatric patients. This role involves analyzing market trends to identify gaps in current treatment options and guiding the research team toward innovative solutions. By managing the lifecycle of spinal products, Gregory Odle drives revenue growth and strengthens the company's market position. The President - Scoliosis also coordinates with clinical experts to validate the efficacy of new procedures, ensuring that every product meets the unique anatomical requirements of children. Through the strategic expansion of the scoliosis portfolio, the President - Scoliosis supports the company's commitment to improving long-term health outcomes for young patients, while simultaneously optimizing the supply chain to ensure consistent product availability across global healthcare networks.

Joe Hauser, the President, Trauma & Deformity Business at OrthoPediatrics, manages the strategic direction and sales operations for the company's core pediatric trauma and deformity correction portfolio. Overseeing the commercial strategy, the President, Trauma & Deformity Business ensures that specialized braces and implants reach healthcare providers efficiently. This role involves leading cross-functional teams to execute product launches and expand market reach within the United States and international territories. By focusing on the specific needs of pediatric trauma cases, Joe Hauser drives the adoption of anatomically appropriate solutions that improve recovery times. The President, Trauma & Deformity Business also collaborates with the executive team to align product development with clinical feedback, ensuring that the company remains at the forefront of orthopedic innovation. Through the optimization of sales channels and the promotion of clinical education, the President, Trauma & Deformity Business secures the company's reputation for excellence in pediatric orthopedic care.

Tim Hinspeter, the President, Trauma Recon Corporate (An Orthopediatrics Distributor) at OrthoPediatrics, directs the distribution logistics and regional market penetration for trauma reconstruction products. Overseeing the distributor network, the President, Trauma Recon Corporate (An Orthopediatrics Distributor) ensures that specialized medical devices are readily available to surgeons performing critical orthopedic procedures. This role involves managing relationships with regional partners to maintain high service levels and product compliance. By streamlining the supply chain, Tim Hinspeter facilitates the rapid delivery of essential implants and instruments to hospitals. The President, Trauma Recon Corporate (An Orthopediatrics Distributor) also monitors regional performance metrics to identify opportunities for growth and operational improvement. Through the effective management of distribution channels, the President, Trauma Recon Corporate (An Orthopediatrics Distributor) supports the company's mission to provide anatomically appropriate care to children, ensuring that the right tools reach the right clinical settings at the right time to maximize patient recovery.